Miller Keith R, Lawson Christy M, Smith Vance L, Harbrecht Brian G
Department of Surgery, University of Louisville, Louisville, KY 40202, USA.
Curr Gastroenterol Rep. 2011 Aug;13(4):388-94. doi: 10.1007/s11894-011-0204-x.
Glycemic control in the critically ill patient has remained a controversial issue over the last decade. Several large trials, with widely varying results, have generated significant interest in defining the optimal target for blood-glucose control necessary for improving care while minimizing morbidity. Nutritional support has evolved into an additional area of critical care where appropriate practices have been associated with improved patient outcomes. Carbohydrate provision can impact blood-glucose levels, and the relationship between nutrition and glucose levels has become more complex in the era of improved glycemic control. This review discusses the controversy surrounding intensive-insulin therapy in the intensive care unit and explores the relationship with nutritional support, both in the enteral and parenteral form. Achieving realistic goals in both carbohydrate provision and glycemic control may improve patient outcome, and are not mutually exclusive practices.
在过去十年中,危重症患者的血糖控制一直是一个有争议的问题。几项大型试验结果差异很大,这引发了人们对确定最佳血糖控制目标的浓厚兴趣,该目标对于改善护理同时将发病率降至最低至关重要。营养支持已发展成为重症监护的一个额外领域,适当的做法与改善患者预后相关。碳水化合物的供应会影响血糖水平,在血糖控制改善的时代,营养与血糖水平之间的关系变得更加复杂。本综述讨论了重症监护病房中强化胰岛素治疗的争议,并探讨了其与肠内和肠外营养支持的关系。在碳水化合物供应和血糖控制方面实现切实可行的目标可能会改善患者预后,而且这两种做法并非相互排斥。